The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney
Open accessAbstract
In the 60 years that have passed since the discovery of the mineralocorticoid hormone aldosterone, much has been learned about its synthesis (both adrenal and extra-adrenal), regulation (by renin-angiotensin II, potassium, adrenocorticotrophin, and other factors), and effects (on both epithelial and nonepithelial tissues). Once thought to be rare, primary aldosteronism (PA, in which aldosterone secretion by the adrenal is excessive and autonomous of its principal regulator, angiotensin II) is now known to be the most common specifically treatable and potentially curable form of hypertension, with most patients lacking the clinical feature of hypokalemia, the presence of which was previously considered to be necessary to warrant further efforts towards confirming a diagnosis of PA. This, and the appreciation that aldosterone excess leads to adverse cardiovascular, renal, central nervous, and psychological effects, that are at least partly independent of its effects on blood pressure, have had a profound influence on raising clinical and research interest in PA. Such research on patients with PA has, in turn, furthered knowledge regarding aldosterone synthesis, regulation, and effects. This review summarizes current progress in our understanding of the physiology of aldosterone, and towards defining the causes (including genetic bases), epidemiology, outcomes, and clinical approaches to diagnostic workup (including screening, diagnostic confirmation, and subtype differentiation) and treatment of PA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Self-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Molecular biology of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 –isomerase gene family
Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H. (2005) · Endocrine Reviews · doi:10.1210/er.2002-0050 · Cited by 620
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Azizan, E. A. B., Poulsen, H., Tuluc, P., Zhou, J., Clausen, M. V., Lieb, A., Maniero, C., Garg, S., Bochukova, E. G., Zhao, W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2716 · Cited by 544
Savard, S., Amar, L., Plouin, P.-F., & Steichen, O. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01060 · Cited by 505
Control of aldosterone secretion: a model for convergence in cellular signaling pathways
SPÄT, A., & HUNYADY, L. (2004) · Physiological Reviews · doi:10.1152/physrev.00030.2003 · Cited by 494
ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome
Assié, G., Libé, R., Espiard, S., Rizk-Rabin, M., Guimier, A., Luscap, W., Barreau, O., Lefèvre, L., Sibony, M., Guignat, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304603 · Cited by 395
Arakane, F., King, S. R., Du, Y., Kallen, C. B., Walsh, L. P., Watari, H., Stocco, D. M., & Strauss, J. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32656 · Cited by 391
Renin angiotensin system and gender differences in the cardiovascular system
Fischer, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00479-5 · Cited by 384
Huby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C. E., Bollag, W. B., Filosa, J. A., & de Chantemèle, E. J. B. (2015) · Circulation · doi:10.1161/circulationaha.115.018226 · Cited by 376
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372
Acute and chronic regulation of aldosterone production
Hattangady, N. G., Olala, L. O., Bollag, W. B., & Rainey, W. E. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.034 · Cited by 347
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure
Oelkers, W. K. H. (1996) · Steroids · doi:10.1016/0039-128x(96)00007-4 · Cited by 333
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma
Fernandes-Rosa, F. L., Williams, T. A., Riester, A., Steichen, O., Beuschlein, F., Boulkroun, S., Strom, T. M., Monticone, S., Amar, L., Meatchi, T., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03419 · Cited by 310
Gallay, B. J., Ahmad, S., Xu, L., Toivola, B., & Davidson, R. C. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80117-7 · Cited by 304
A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism
Geller, D. S., Zhang, J., Wisgerhof, M. V., Shackleton, C., Kashgarian, M., & Lifton, R. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0594 · Cited by 296
Štrauch, B., Zelinka, T., Hampf, M., Bernhardt, R., & Widimsky, J. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001554 · Cited by 237
Burton, T. J., Mackenzie, I. S., Balan, K., Koo, B., Bird, N., Soloviev, D. V., Azizan, E. A. B., Aigbirhio, F., Gurnell, M., & Brown, M. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1537 · Cited by 226
Giacchetti, G., Ronconi, V., Turchi, F., Agostinelli, L., Mantero, F., Rilli, S., & Boscaro, M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280108e6f · Cited by 196
Peitzsch, M., Dekkers, T., Haase, M., Sweep, F. C. G. J., Quack, I., Antoch, G., Siegert, G., Lenders, J. W. M., Deinum, J., Willenberg, H. S., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.10.006 · Cited by 169
ARMC5 Mutations Are a Frequent Cause of Primary Macronodular Adrenal Hyperplasia
Alencar, G. A., Lerario, A. M., Nishi, M. Y., Mariani, B. M. D. P., Almeida, M. Q., Tremblay, J., Hamet, P., Bourdeau, I., Zerbini, M. C. N., Pereira, M. A. A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4237 · Cited by 162
Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma
Zheng, F.-F., Zhu, L.-M., Nie, A.-F., Li, X.-Y., Lin, J.-R., Zhang, K., Chen, J., Zhou, W.-L., Shen, Z.-J., Zhu, Y.-C., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.03346 · Cited by 151
Disorders of steroid 17α-hydroxylase deficiency
Kater, C. E., & Biglieri, E. G. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30101-4 · Cited by 146
Bernini, G., Galetta, F., Franzoni, F., Bardini, M., Taurino, C., Bernardini, M., Ghiadoni, L., Bernini, M., Santoro, G., & Salvetti, A. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831286fd · Cited by 136
Fan, J., Campioli, E., Midzak, A., Culty, M., & Papadopoulos, V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502670112 · Cited by 133
Pseudohyperkalemia Caused by Fist Clenching during Phlebotomy
Don, B. R., Sebastian, A., Cheitlin, M., Christiansen, M., & Schambelan, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221806 · Cited by 132
PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells
Mazzocchi, G., Aragona, F., Malendowicz, L. K., & Nussdorfer, G. G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e209 · Cited by 123
Pilz, S., Kienreich, K., Drechsler, C., Ritz, E., Fahrleitner-Pammer, A., Gaksch, M., Meinitzer, A., März, W., Pieber, T. R., & Tomaschitz, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2183 · Cited by 118
Narasaka, T., Suzuki, T., Moriya, T., & Sasano, H. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00445-7 · Cited by 109
Ahmed, A. H., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., & Stowasser, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1355 · Cited by 96 · cited 1×
“We reported luteal concentrations of plasma aldosterone, DRC, and PRA to be higher than follicular in 19 healthy, normotensive females (12).”
BackgroundSelf-citationBrunaud, L., Germain, A., Zarnegar, R., Rancier, M., Alrasheedi, S., Caillard, C., Ayav, A., Weryha, G., Mirallie, E., & Bresler, L. (2009) · Surgery · doi:10.1016/j.surg.2009.09.041 · Cited by 83
ISALES, C. M., BARRETT, P. Q., BRINES, M., BOLLAG, W., & RASMUSSEN, H. (1991) · Endocrinology · doi:10.1210/endo-129-1-489 · Cited by 72
Pimenta, E., Stowasser, M., Gordon, R. D., Harding, S. M., Batlouni, M., Zhang, B., Oparil, S., & Calhoun, D. A. (2013) · Chest · doi:10.1378/chest.12-0802 · Cited by 69
Self-citationKovacs, L., Goth, M., Szabolcs, I., Dohan, O., Ferencz, A., & Szilagyi, G. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380543 · Cited by 66
Lenzini, L., Caroccia, B., Campos, A. G., Fassina, A., Belloni, A. S., Seccia, T. M., Kuppusamy, M., Ferraro, S., Skander, G., Bader, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2900 · Cited by 59
Vasopressin: A potent autocrine/paracrine regulator of mammal adrenal functions.
Guillon, G., Grazzini, E., Andrez, M., Breton, C., Trueba, M., Gal, C. S.-L., Boccara, G., Derick, S., Chouinard, L., & Gallo-payet, N. (1998) · Endocrine Research · doi:10.3109/07435809809032672 · Cited by 55
Cited by
Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease
Lacolley, P., Regnault, V., Segers, P., & Laurent, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00003.2017 · Cited by 734
Metadata
- Authors
- Stowasser, M., & Gordon, R. D.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2016-10
- Volume
- 96
- Issue
- 4
- Pages
- 1327-1384
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2507510102
- Cited by
- 159
- References
- 40
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
